KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Other Working Capital Changes (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Other Working Capital Changes for 7 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes rose 105.12% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 113.13% year-over-year, with the annual reading at $1.8 million for FY2025, 113.13% up from the prior year.
  • Other Working Capital Changes hit $1.3 million in Q4 2025 for GoodRx Holdings, up from -$15.3 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $37.4 million in Q2 2021 to a low of -$52.9 million in Q3 2021.
  • Historically, Other Working Capital Changes has averaged -$739368.4 across 5 years, with a median of $6.0 million in 2024.
  • Biggest five-year swings in Other Working Capital Changes: skyrocketed 3206.54% in 2021 and later crashed 371.43% in 2023.
  • Year by year, Other Working Capital Changes stood at -$11.4 million in 2021, then skyrocketed by 192.46% to $10.5 million in 2022, then plummeted by 371.43% to -$28.5 million in 2023, then increased by 8.63% to -$26.1 million in 2024, then surged by 105.12% to $1.3 million in 2025.
  • Business Quant data shows Other Working Capital Changes for GDRX at $1.3 million in Q4 2025, -$15.3 million in Q3 2025, and $2.3 million in Q2 2025.